250 jobs coming to Durham in the Triangle area according to the press release.
“Aurobindo Pharma USA is a unit of Aurobindo Pharma Limited, headquartered in Hyderabad, India. The publicly-held parent company (BSE: AUROPHARMA) was founded in 1986. It is a leading maker of semi-synthetic penicillins and offers therapeutics for neurosciences, cardiovascular, anti-retrovirals, anti-diabetics and gastroenterology. In 2015, Forbes Asia named Aurobindo Pharma to its “Fabulous 50” list. The company employs a worldwide workforce of 15,500….
…Aurobindo Pharma USA will establish a new R&D and manufacturing center in Durham. The company currently employs 14 scientists/workers in Raleigh. Among the new employees will be researchers, analytical chemists, production operators, quality control specialists and others. Aurobindo’s expanded operations in North Carolina will create a $17.1 million annual payroll impact for Durham and surrounding counties.
“We are very excited about our plans for expansion of our specialty pharma R&D and manufacturing in North Carolina, and are thankful to EDPNC, Durham City, Durham County and the State of North Carolina for supporting our decision. North Carolina has one of the best talent pools in the specialty pharma R&D and manufacturing sectors, and we look forward to establishing a large and successful footprint here,” said Dr. Ninad Deshpanday, President, R&D, Aurobindo Pharma USA, Inc.” according to the press release.